
|Articles|August 6, 2019
Technology Matters: Next-Generation RNA-Based Diagnostics Improve Disease Detection
Advertisement
Recent advancements in nucleic acid amplification tests (NAATs) have enabled clinicians to diagnose patients with improved accuracy for important pathogens. But are clinicians impeded by common misconceptions about available tools, or even key differences between DNA and RNA?
This supplement accurately explains the science of RNA-based testing modalities and reviews methods and results of assays for Mycoplasma genitalium, bacterial vaginosis, vulvovaginal candidiasis, Trichomonas vaginalis, and human papillomavirus.
Disclosures:
References:
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Ultra-processed food intake linked to higher mortality among Black women with breast cancer
2
Joshua Hare, MD, FAAC, highlights stem cell therapy for female sexual dysfunction
3
Cervical cancer screening adherence remains low in US patients
4
Contraception year in review 2025
5







